Wild-type BRAF is required for response to panitumumab or cetuximab in metastatic colorectal cancer (Q27851456)
scientific article
Language:
Current Data About Wild-type BRAF is required for response to panitumumab or cetuximab in metastatic colorectal cancer
(P31) (Q13442814)
(P248)
(P698) 19001320
(P813) Sunday, November 13, 2016

(P50) (Q28321686)
(P1545) 1

(Q28321693)
(P1545) 4

(Q28321691)
(P1545) 11

(Q28321703)
(P1545) 10

(Q38324358)
(P1932) Miriam Martini
(P1545) 2

(Q56989591)
(P1932) Sabrina Arena
(P1545) 5

(P304) 5705-12

(P407) (Q1860)

(P433) 35

(P478) 26

(P577) Wednesday, December 10, 2008

(P921) (Q188874)
(P887)

(Q420296)
(P887)

(Q108566365)
(P887)

(Q25493920)
(P887)

(P1433) (Q400292)

(P1476) "Wild-type BRAF is required for response to panitumumab or cetuximab in metastatic colorectal cancer" (language: en)
(P248)
(P698) 19001320
(P813) Sunday, November 13, 2016

(P2093) Francesca Molinari
(P1545) 3

Piercarlo Saletti
(P1545) 6

Sara De Dosso
(P1545) 7

Luca Mazzucchelli
(P1545) 8

Milo Frattini
(P1545) 9

other details
description scientific article

External Links
(P356) 10.1200/JCO.2008.18.0786
(P698) 19001320
(P3181) 118912
(P5875) 23465803